SEP 11, 2026 · PHASE 2 TRIAL
A Study of Tirzepatide (LY3298176) in Participants With Overweight or Obesity and Chronic Kidney Disease With or Without Type 2 Diabetes
ClinicalTrials.gov
Phase 2 registry record with completed enrollment but no results posted; insufficient to assess efficacy or safety, only study design and conduct are known.
Reported
Planned enrollment134
PhasePhase 2
Primary outcome measurePercent Change from Baseline in Renal Sinus…